AZD0328 is an experimental drug. It is a selective α7 nicotinic receptor agonist that enhances cortical dopamine release and improves learning and attentional processes in rats.[1]
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C13H16N2O |
Molar mass | 216.284 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
References
edit- ^ Sydserff S, Sutton EJ, Song D, Quirk MC, Maciag C, Li C, et al. (October 2009). "Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes". Biochemical Pharmacology. 78 (7): 880–8. doi:10.1016/j.bcp.2009.07.005. PMID 19615981.